(Q37891477)

English

Spondyloarthritis

scientific article published on June 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

24 August 2017

1 reference

Europe PubMed Central

Spondyloarthritis. (English)

1 reference

Europe PubMed Central

24 August 2017

Maxime Dougados

1

object named as

Maxime Dougados

1 reference

Europe PubMed Central

24 August 2017

author name string

Dominique Baeten

2

1 reference

Europe PubMed Central

24 August 2017

language of work or name

0 references

publication date

1 June 2011

1 reference

Europe PubMed Central

24 August 2017

1 reference

Europe PubMed Central

24 August 2017

377

1 reference

Europe PubMed Central

24 August 2017

2127-2137

1 reference

Europe PubMed Central

24 August 2017

9783

1 reference

Europe PubMed Central

24 August 2017

Associations between ankylosing spondylitis, psoriatic arthritis, Reiter's disease, the intestinal arthropathies, and Behcet's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human beta 2m: an animal model of HLA-B27-associated human disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Defining active sacroiliitis on magnetic resonance imaging (MRI) for classification of axial spondyloarthritis: a consensual approach by the ASAS/OMERACT MRI group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Spinal inflammation lesions as detected by magnetic resonance imaging in patients with early ankylosing spondylitis are more often observed in posterior structures of the spine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

How to evaluate and improve the reliability of power Doppler ultrasonography for assessing enthesitis in spondylarthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Validity of enthesis ultrasound assessment in spondyloarthropathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Enthesis inflammation in recurrent acute anterior uveitis without spondylarthritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Performance of referral recommendations in patients with chronic back pain and suspected axial spondyloarthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Genetics and genomics of ankylosing spondylitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular mimicry of an HLA-B27-derived ligand of arthritis-linked subtypes with chlamydial proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Recurrence risk modelling of the genetic susceptibility to ankylosing spondylitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Prospective meta-analysis of interleukin 1 gene complex polymorphisms confirms associations with ankylosing spondylitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The chromosome 16q region associated with ankylosing spondylitis includes the candidate gene tumour necrosis factor receptor type 1-associated death domain (TRADD)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Comprehensive linkage and association analyses identify haplotype, near to the TNFSF15 gene, significantly associated with spondyloarthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Elucidating the chromosome 9 association with AS; CARD9 is a candidate gene

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Phenotypic diversity is not determined by independent genetic factors in familial spondylarthropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Additional human beta2-microglobulin curbs HLA-B27 misfolding and promotes arthritis and spondylitis without colitis in male HLA-B27-transgenic rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

HLA-B27-restricted CD8 T cells derived from synovial fluids of patients with reactive arthritis and ankylosing spondylitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

HLA-B27-restricted CD8+ T cell response to cartilage-derived self peptides in ankylosing spondylitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

CD8 alpha beta T cells are not essential to the pathogenesis of arthritis or colitis in HLA-B27 transgenic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Spondylarthritis in HLA-B27/human beta2-microglobulin-transgenic rats is not prevented by lack of CD8.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

HLA-B27 heavy chain homodimers are expressed in HLA-B27 transgenic rodent models of spondyloarthritis and are ligands for paired Ig-like receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Expansion and enhanced survival of natural killer cells expressing the killer immunoglobulin-like receptor KIR3DL2 in spondylarthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

HLA-B27 misfolding is associated with aberrant intermolecular disulfide bond formation (dimerization) in the endoplasmic reticulum

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

HLA-B27 misfolding in transgenic rats is associated with activation of the unfolded protein response.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Endoplasmic reticulum stress and the unfolded protein response are linked to synergistic IFN-beta induction via X-box binding protein 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

HLA-B27 misfolding and the unfolded protein response augment interleukin-23 production and are associated with Th17 activation in transgenic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Tumor necrosis factor alpha blockade treatment down-modulates the increased systemic and local expression of Toll-like receptor 2 and Toll-like receptor 4 in spondylarthropathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Toll-like receptor 2 variants are associated with acute reactive arthritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The concept of a "synovio-entheseal complex" and its implications for understanding joint inflammation and damage in psoriatic arthritis and beyond

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Macrophages expressing the scavenger receptor CD163: a link between immune alterations of the gut and synovial inflammation in spondyloarthropathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Infiltration of the synovial membrane with macrophage subsets and polymorphonuclear cells reflects global disease activity in spondyloarthropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

A proposed classification of the immunological diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Mesenchymal cell targeting by TNF as a common pathogenic principle in chronic inflammatory joint and intestinal diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Absence of a classically activated macrophage cytokine signature in peripheral spondylarthritis, including psoriatic arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Soluble human p55 and p75 tumor necrosis factor receptors reverse spontaneous arthritis in transgenic mice expressing transmembrane tumor necrosis factor alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased numbers of circulating polyfunctional Th17 memory cells in patients with seronegative spondylarthritides

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Frequency and phenotype of peripheral blood Th17 cells in ankylosing spondylitis and rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Systemic levels of IL-23 are strongly associated with disease activity in rheumatoid arthritis but not spondyloarthritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Overexpression of interleukin-23, but not interleukin-17, as an immunologic signature of subclinical intestinal inflammation in ankylosing spondylitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Histopathologic evidence that sacroiliitis in ankylosing spondylitis is not merely enthesitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Distinct topography of erosion and new bone formation in achilles tendon enthesitis: Implications for understanding the link between inflammation and bone formation in spondylarthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Involvement of matrix metalloproteinases and their inhibitors in peripheral synovitis and down-regulation by tumor necrosis factor alpha blockade in spondylarthropathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The abundant synovial expression of the RANK/RANKL/Osteoprotegerin system in peripheral spondylarthritis is partially disconnected from inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Tumor necrosis factor alpha drives cadherin 11 expression in rheumatoid inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Mediators of structural remodeling in peripheral spondylarthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Modulation of bone morphogenetic protein signaling inhibits the onset and progression of ankylosing enthesitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Dickkopf-1 is a master regulator of joint remodeling

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Blockade of Dickkopf (DKK)-1 induces fusion of sacroiliac joints.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Evidence that Dkk-1 is dysfunctional in ankylosing spondylitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Altered skeletal expression of sclerostin and its link to radiographic progression in ankylosing spondylitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Critical appraisal of assessment of structural damage in ankylosing spondylitis: implications for treatment outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The relationship between inflammation and new bone formation in patients with ankylosing spondylitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Inflammatory lesions of the spine on magnetic resonance imaging predict the development of new syndesmophytes in ankylosing spondylitis: Evidence of a relationship between inflammation and new bone formation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Tumor necrosis factor α and RANKL blockade cannot halt bony spur formation in experimental inflammatory arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of osteoclasts does not prevent joint ankylosis in a mouse model of spondyloarthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Evidence for uncoupling of inflammation and joint remodeling in a mouse model of spondylarthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Progress in spondylarthritis. Mechanisms of new bone formation in spondyloarthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis, before and after successful therapy with infliximab: evaluation of a new scoring system

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Spondyloarthritis research consortium of canada magnetic resonance imaging index for assessment of spinal inflammation in ankylosing spondylitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Magnetic resonance imaging grading system for active and chronic spondylarthritis changes in the sacroiliac joint

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

[MR Imaging of the spine and sacroiliac joints in ankylosing spondylitis]

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Magnetic resonance imaging assessment of spinal inflammation in ankylosing spondylitis: standard clinical protocols may omit inflammatory lesions in thoracic vertebrae

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Systematic assessment of inflammation by magnetic resonance imaging in the posterior elements of the spine in ankylosing spondylitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Validation of whole-body against conventional magnetic resonance imaging for scoring acute inflammatory lesions in the sacroiliac joints of patients with spondylarthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessment of active spinal inflammatory changes in patients with axial spondyloarthritis: validation of whole body MRI against conventional MRI.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Adalimumab significantly reduces both spinal and sacroiliac joint inflammation in patients with ankylosing spondylitis: A multicenter, randomized, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Low-dose Infliximab (3 mg/kg) Significantly Reduces Spinal Inflammation on Magnetic Resonance Imaging in Patients with Ankylosing Spondylitis: A Randomized Placebo-controlled Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Responsiveness of the Ankylosing Spondylitis Disease Activity Score (ASDAS) and clinical and MRI measures of disease activity in a 1-year follow-up study of patients with axial spondyloarthritis treated with tumour necrosis factor alpha inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical and imaging efficacy of infliximab in HLA-B27-Positive patients with magnetic resonance imaging-determined early sacroiliitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomised, multicentre, double-blind, placebo-controlled trial of etanercept in adults with refractory heel enthesitis in spondyloarthritis: the HEEL trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

What is the most appropriate radiologic scoring method for ankylosing spondylitis? A comparison of the available methods based on the Outcome Measures in Rheumatology Clinical Trials filter

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Development of a radiographic scoring tool for ankylosing spondylitis only based on bone formation: addition of the thoracic spine improves sensitivity to change

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

ASAS/EULAR recommendations for the management of ankylosing spondylitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

First update of the international ASAS consensus statement for the use of anti-TNF agents in patients with ankylosing spondylitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Physiotherapy interventions for ankylosing spondylitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical relevance of C-reactive protein in ankylosing spondylitis and evaluation of the NSAIDs/coxibs' treatment effect on C-reactive protein

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Comorbidity profiles among patients with ankylosing spondylitis: a nationwide population-based study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Sulfasalazine for ankylosing spondylitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Methotrexate for ankylosing spondylitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Double blind, randomised, placebo controlled study of leflunomide in the treatment of active ankylosing spondylitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of thalidomide in the treatment of refractory ankylosing spondylitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

One-year open-label trial of thalidomide in ankylosing spondylitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

A six-month randomized, controlled, double-blind, dose-response comparison of intravenous pamidronate (60 mg versus 10 mg) in the treatment of nonsteroidal antiinflammatory drug-refractory ankylosing spondylitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of a loading dose regimen of three infusions of chimeric monoclonal antibody to tumour necrosis factor alpha (infliximab) in spondyloarthropathy: an open pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Successful treatment of active ankylosing spondylitis with the anti-tumor necrosis factor alpha monoclonal antibody infliximab

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor alpha (infliximab) versus placebo in active spondylarthropathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Crohn's disease associated with spondyloarthropathy: effect of TNF-alpha blockade with infliximab on articular symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of adalimumab in the treatment of axial spondylarthritis without radiographically defined sacroiliitis: results of a twelve-week randomized, double-blind, placebo-controlled trial followed by an open-label extension up to week fifty-two

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Systematic safety follow up in a cohort of 107 patients with spondyloarthropathy treated with infliximab: a new perspective on the role of host defence in the pathogenesis of the disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three-year prospective French Research Axed on Tolerance of Biotherapies registry

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk of Herpes Zoster in Patients With Rheumatoid Arthritis Treated With Anti–TNF-α Agents

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Prediction of a major clinical response (BASDAI 50) to tumour necrosis factor alpha blockers in ankylosing spondylitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

MRI in predicting a major clinical response to anti-tumour necrosis factor treatment in ankylosing spondylitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Real life experience confirms sustained response to long-term biologics and switching in ankylosing spondylitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Sustained response to long-term biologics and switching in psoriatic arthritis: results from real life experience.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical response to discontinuation of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Infliximab inhibits progression of radiographic damage in patients with active psoriatic arthritis through one year of treatment: Results from the induction and maintenance psoriatic arthritis clinical trial 2

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiographic progression of ankylosing spondylitis after up to two years of treatment with etanercept.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiographic findings following two years of infliximab therapy in patients with ankylosing spondylitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessment of radiographic progression in the spines of patients with ankylosing spondylitis treated with adalimumab for up to 2 years

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Rituximab in the spondyloarthropathies: data of eight patients followed up in the French Autoimmunity and Rituximab (AIR) registry

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Different response to rituximab in tumor necrosis factor blocker-naive patients with active ankylosing spondylitis and in patients in whom tumor necrosis factor blockers have failed: a twenty-four-week clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Efalizumab for the treatment of psoriatic arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Alefacept in combination with methotrexate for the treatment of psoriatic arthritis: results of a randomized, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Open label trial of anakinra in active ankylosing spondylitis over 24 weeks

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Ustekinumab, a human interleukin 12/23 monoclonal antibody, for psoriatic arthritis: randomised, double-blind, placebo-controlled, crossover trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960071-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(11)60071-8

1 reference

Europe PubMed Central

24 August 2017

1 reference

Europe PubMed Central

24 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37891477&oldid=2114548597"